This inventor holds 2 USPTO granted patents. Top assignee: Changchun Institute of Biological Products, Ministry of Public Health. Active years: 2003-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2005
Title: Baosheng Xie: Innovator in Vaccine Development
Introduction
Baosheng Xie is a prominent inventor based in Changchun, China. He has made significant contributions to the field of vaccine development, particularly in the area of hepatitis A and measles vaccines. With a total of 2 patents, his work has the potential to impact public health positively.
Latest Patents
Xie's latest patents include a freeze-dried hepatitis A attenuated live vaccine and its stabilizer. This invention relates to a lyophilized attenuated hepatitis A vaccine that can be stored at ambient temperature for extended periods. It also includes a method for producing the vaccine and a stabilizer that improves the thermostability of the vaccine during processing and storage. Another notable patent is a combined vaccine against both hepatitis A and measles virus. This combined live vaccine is designed to prevent infections without causing interference between the two viruses' antigenicity or serious adverse events.
Career Highlights
Baosheng Xie works at the Changchun Institute of Biological Products, which is part of the Ministry of Public Health. His role at this institution has allowed him to focus on innovative vaccine research and development, contributing to advancements in public health.
Collaborations
Xie has collaborated with notable coworkers, including Shuyan Li and Pengfu Wang. Their teamwork has been instrumental in advancing the research and development of vaccines.
Conclusion
Baosheng Xie's contributions to vaccine development, particularly through his innovative patents, highlight his importance in the field of public health. His work continues to pave the way for improved vaccine stability and efficacy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile